CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression-Reference-Cited by-同舟云学术

CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression

Published:2008-04-27 Issue:5 Volume:26 Page:549-551
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Hyde Stephen C,Pringle Ian A,Abdullah Syahril,Lawton Anna E,Davies Lee A,Varathalingam Anusha,Nunez-Alonso Graciela,Green Anne-Marie,Bazzani Reto P,Sumner-Jones Stephanie G,Chan Mario,Li Hongyu,Yew Nelson S,Cheng Seng H,Christopher Boyd A,Davies Jane C,Griesenbach Uta,Porteous David J,Sheppard David N,Munkonge Felix M,Alton Eric W F W,Gill Deborah R

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt1399.pdf

Reference15 articles.

1. Hyde, S.C. et al. Gene Ther. 7, 1156–1165 (2000).

2. Alton, E.W. et al. Lancet 353, 947–954 (1999).

3. Eastman, S.J. et al. Hum. Gene Ther. 8, 765–773 (1997).

4. Gill, D.R. et al. Gene Ther. 8, 1539–1546 (2001).

5. Pringle, I.A. et al. Gene Ther. 12, 1206–1214 (2005).

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly branched poly β-amino ester/CpG-depleted CFTR plasmid nanoparticles for non-viral gene therapy in lung cystic fibrosis disease;Molecular Therapy - Methods & Clinical Development;2024-09

2. Construction of pVAX-1-based linear covalently closed vector with improved transgene expression;Molecular Biology Reports;2024-08-24

3. A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines;Advanced Drug Delivery Reviews;2024-06

4. Suitable Promoter for DNA Vaccination Using a pDNA Ternary Complex;Pharmaceutics;2024-05-17

5. Exploiting a Type III Interferon Response to Improve Chemotherapeutic Safety and Efficacy;2024-05-03